Products

What will AGI do for Acifran?

This classification denotes an anti-lipidemic agent with the molecular formula C12H10O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B1X701S0MV, chemically known as 4,5-dihydro-5-methyl-4-oxo-5-phenyl-2-furancarboxylic acid but generally known as acifran, which bears US NIH Compound Identifier 51576. European Medicines Agency schedules Acifran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05236MIG. The term ACIFRAN is an International Non-Proprietary Name. ACIFRAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acifran under HS 29321900 and SITC 51569. As of Q4 2014, ACIFRAN remains the US FDA Preferred Term for this commodity. Acifran bears US NLM identifiers UMLS ID C0052730 and NCI Concept Code C81534. SMILES: CC1(C(=O)C=C(O1)C(=O)O)C2=CC=CC=C2.

How AGI delivers it

Four ways AGI delivers for Acifran

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Acifran, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Acifran, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Acifran connects

measured by

  • Assay Puritymodel
  • Particle Size Distributionmodel
  • Related Substancesmodel
  • Residual Solventsmodel